echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Dojolvi on the market in the U.S.: the first long-chain fatty acid oxidation metabolic disease drug!

    Dojolvi on the market in the U.S.: the first long-chain fatty acid oxidation metabolic disease drug!

    • Last Update: 2020-08-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    Dojolvi is a high-purity, pharmaceutical grade, medium-chain triglycerides that connect three seven-carbon fatty acids to synthetic seven-carbon fatty acid triglycerides produced on a glycerin skeleton through a multi-step chemical process.
    the drug is designed to provide patients with medium-length odd-chain fatty acids that can be metabolized in the Krebs cycle during the critical energy generation process to increase the intermediate substrate, thereby directly addressing LC-FAOD defects.
    unlike typical even-chain fatty acids, an intermediate produced by Dojolvi through Krebs cycle can also be converted into new glucose, which may provide important additional therapeutic effects, especially when glucose levels are too low.
    original source: Ultragenyx Announces U.S. Commercial Launch of Dojolvi ™ (Triheptanoin), the FirstFDA-approved therapy for the Treatment of the Long-Long-Chain Fatty Acid Oxidation SanIc Samen Sazzs Original Title: 20 Years of Rare Diseases! Dojolvi on the market in the U.S.: The first long-chain fatty acid oxidation metabolic disease (LC-FAOD) drug!
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.